The Fast Track review process - unique to the EHJ - was created to permit prompt dissemination of important scientific findings in cardiology. For many years, this expedited peer review process has been offered to presenters of ESC Hotline and Clinical Trial Update papers for the timely presentation of their findings.
The selected papers below published online, coinciding with their presentation at the ESC Congress, August 2016.
Sunday 28th August
Monday 29th August
Comparative Efficacy of Coronary Artery Bypass Surgery Versus Percutaneous Coronary Intervention in Patients with Diabetes and Multivessel Coronary Artery Disease With or Without Chronic Kidney Disease
Tuesday 30th September
Ten-Year Clinical Outcomes of First-Generation Drug-Eluting Stents Results of the Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization (SIRTAX) VERY LATE Trial
Kyohei Yamaji; Stephan Windecker
Although diseases of the heart and blood vessels (cardiovascular disease, CVD) kill more people worldwide than anything else, with 17.3 million deaths globally, cancer has now overtaken CVD as the main cause of death in 12 European countries.
New data on the burden of CVD in Europe for 2016 shows that in the European region (defined as the 53 member states of the World Health Organisation) CVD caused more than four million deaths each year, 45% of all deaths. However, success in preventing and treating the disease has led to large decreases in CVD in a number of countries.
The EHJ Today team explored the hot topics and latest news from key figures in the cardiology community at this year's ESC Congress. Be the first to watch the interviews.